Cargando…
Adverse events related to low dose corticosteroids in autoimmune hepatitis
BACKGROUND: Autoimmune hepatitis requires long‐term therapy, and systemic corticosteroids are the backbone of therapeutic management. Prolonged use of corticosteroids may lead to adverse events but data from long‐term studies are mainly derived from studies in rheumatic diseases. AIM: To assess cata...
Autores principales: | van den Brand, Floris F., van der Veen, Koen S., Lissenberg‐Witte, Birgit I., de Boer, Ynto S., van Hoek, Bart, Drenth, Joost P. H., Verdonk, Robert C., Vrolijk, Jan M., van Nieuwkerk, Carin M. J., Bouma, Gerd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899908/ https://www.ncbi.nlm.nih.gov/pubmed/31617229 http://dx.doi.org/10.1111/apt.15528 |
Ejemplares similares
-
Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands
por: van den Brand, Floris F., et al.
Publicado: (2018) -
Early predictors of corticosteroid response in acute severe autoimmune hepatitis: a nationwide multicenter study
por: Téllez, Luis, et al.
Publicado: (2022) -
A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases
por: Kastrati, Kastriot, et al.
Publicado: (2022) -
Functional Analysis of a Complement Polymorphism (rs17611) Associated with Rheumatoid Arthritis
por: Giles, Joanna L., et al.
Publicado: (2015) -
Automated evaluation of ANA under real-life conditions
por: Loock, Clemens Dario, et al.
Publicado: (2017)